Exactech, Inc. (NASDAQ:EXAC) Stake Held by Fmr LLC

FMR LLC maintained its position in shares of Exactech, Inc. (NASDAQ:EXAC) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 166,167 shares of the medical equipment provider’s stock at the end of the first quarter. FMR LLC owned about 1.16% of Exactech worth $4,187,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. State Street Corp boosted its position in shares of Exactech by 11.3% in the fourth quarter. State Street Corp now owns 245,639 shares of the medical equipment provider’s stock worth $6,707,000 after buying an additional 25,011 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Exactech by 4.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 751,750 shares of the medical equipment provider’s stock worth $20,523,000 after buying an additional 29,515 shares during the period. Renaissance Technologies LLC boosted its position in shares of Exactech by 7.2% in the fourth quarter. Renaissance Technologies LLC now owns 105,700 shares of the medical equipment provider’s stock worth $2,886,000 after buying an additional 7,100 shares during the period. Foundry Partners LLC boosted its position in shares of Exactech by 205.9% in the first quarter. Foundry Partners LLC now owns 155,436 shares of the medical equipment provider’s stock worth $3,917,000 after buying an additional 104,625 shares during the period. Finally, Rice Hall James & Associates LLC boosted its position in shares of Exactech by 74.1% in the first quarter. Rice Hall James & Associates LLC now owns 99,270 shares of the medical equipment provider’s stock worth $2,502,000 after buying an additional 42,256 shares during the period. Institutional investors own 64.05% of the company’s stock.

Exactech, Inc. (EXAC) opened at 29.95 on Friday. The stock has a 50 day moving average price of $29.41 and a 200 day moving average price of $28.11. The stock has a market cap of $429.72 million, a PE ratio of 575.96 and a beta of 1.02. Exactech, Inc. has a 52 week low of $22.20 and a 52 week high of $31.90.

Exactech (NASDAQ:EXAC) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $0.33 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.33. Exactech had a return on equity of 7.39% and a net margin of 0.30%. The company had revenue of $67.30 million during the quarter, compared to the consensus estimate of $67.75 million. During the same quarter in the prior year, the business earned $0.31 earnings per share. The company’s revenue was up 1.8% compared to the same quarter last year. On average, equities analysts predict that Exactech, Inc. will post $1.29 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Exactech, Inc. (NASDAQ:EXAC) Stake Held by Fmr LLC” was first reported by BNB Daily and is the property of of BNB Daily. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.baseball-news-blog.com/2017/08/19/exactech-inc-nasdaqexac-stake-maintained-by-fmr-llc-updated-updated.html.

Several equities analysts have recently issued reports on EXAC shares. Zacks Investment Research upgraded Exactech from a “sell” rating to a “hold” rating in a research note on Tuesday, April 25th. TheStreet upgraded Exactech from a “c+” rating to a “b” rating in a research note on Tuesday, April 25th. BidaskClub cut Exactech from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Finally, Gabelli reiterated a “buy” rating on shares of Exactech in a research note on Monday, July 31st.

In related news, CFO Joel C. Phillips sold 7,610 shares of the stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $30.71, for a total value of $233,703.10. Following the completion of the transaction, the chief financial officer now owns 99,907 shares of the company’s stock, valued at $3,068,143.97. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William B. Locander sold 988 shares of the stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $30.34, for a total value of $29,975.92. Following the completion of the transaction, the director now directly owns 8,555 shares of the company’s stock, valued at approximately $259,558.70. The disclosure for this sale can be found here. Insiders sold 10,358 shares of company stock valued at $314,311 in the last ninety days. Company insiders own 28.30% of the company’s stock.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply